Bukwang Pharmaceutical surged in early trading on the 25th. Buying appeared to gather after word spread that the company delivered positive results and finalized a dividends policy to boost shareholder value at the regular shareholders meeting held the previous day.
As of 9:24 a.m. that day on the Korea Exchange, Bukwang Pharmaceutical was trading at 7,630 won, up 520 won (7.31%) from the previous session.
The previous day, Bukwang Pharmaceutical held its regular shareholders meeting at its headquarters in Dongjak District, Seoul, and said last year's sales topped 200 billion won for the first time ever.
Bukwang Pharmaceutical will also implement a dividends policy to enhance shareholder value. At this shareholders meeting, Bukwang Pharmaceutical finalized total dividends of 12.32208 billion won, combining the interim dividend (50 won per share) paid in November last year and the year-end dividend (75 won per share).